Combination therapy with topical minoxidil and nano-microneedle-assisted fibroblast growth factor for male androgenetic alopecia: a randomized controlled trial in Chinese patients

Chin Med J (Engl). 2020 Nov 5;134(7):851-853. doi: 10.1097/CM9.0000000000001195.

Authors

Cheng-Qian Yu¹, Hui Zhang², Meng-Er Guo¹, Xiao-Kun Li³, Hong-Duo Chen¹, Yuan-Hong Li¹, Xue-Gang Xu¹

Affiliations

¹ Department of Dermatology, No. 1 Hospital of China Medical University, Shenyang, Liaoning 110001, China.
² NHC Key Laboratory of Immunodermatology (China Medical University), Liaoning 110001, China.
³ School of Pharmacy, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Administration, Topical
Alopecia / drug therapy
China
Double-Blind Method
Fibroblast Growth Factors* / therapeutic use
Hair
Humans
Male
Minoxidil* / therapeutic use
Treatment Outcome

Substances

Minoxidil
Fibroblast Growth Factors